These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2169974)

  • 21. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
    Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
    Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
    Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma.
    Shipman R; Schraml P; Colombi M; Ludwig CU
    Int J Oncol; 1998 Jan; 12(1):107-11. PubMed ID: 9454893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent loss of chromosome 9 in human primary non-small cell lung cancer.
    Merlo A; Gabrielson E; Askin F; Sidransky D
    Cancer Res; 1994 Feb; 54(3):640-2. PubMed ID: 8306323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group.
    Berenson JR; Koga H; Yang J; Pearl J; Holmes EC; Figlin R
    Oncogene; 1990 Sep; 5(9):1343-8. PubMed ID: 2170896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
    Chmara M; Wozniak A; Ochman K; Kobierska G; Dziadziuszko R; Sosinska-Mielcarek K; Jassem E; Skokowski J; Jassem J; Limon J
    Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
    Mitsudomi T; Oyama T; Nishida K; Ogami A; Osaki T; Sugio K; Yasumoto K; Sugimachi K; Gazdar AF
    Clin Cancer Res; 1996 Jul; 2(7):1185-9. PubMed ID: 9816286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative genomic hybridization of bronchial carcinomas and their metastases].
    Petersen I; Petersen S; Bockmühl U; Schwendel A; Wolf G; Dietel M
    Verh Dtsch Ges Pathol; 1997; 81():297-305. PubMed ID: 9474883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer.
    Wistuba II; Behrens C; Virmani AK; Milchgrub S; Syed S; Lam S; Mackay B; Minna JD; Gazdar AF
    Cancer Res; 1999 Apr; 59(8):1973-9. PubMed ID: 10213509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
    Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.
    Iijima H; Tomizawa Y; Dobashi K; Saito R; Nakajima T; Mori M
    Br J Cancer; 2004 Sep; 91(6):1143-8. PubMed ID: 15292942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.
    Sato S; Nakamura Y; Tsuchiya E
    Cancer Res; 1994 Nov; 54(21):5652-5. PubMed ID: 7923212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.
    Horio Y; Takahashi T; Kuroishi T; Hibi K; Suyama M; Niimi T; Shimokata K; Yamakawa K; Nakamura Y; Ueda R
    Cancer Res; 1993 Jan; 53(1):1-4. PubMed ID: 8380124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation.
    Cooper CA; Bubb VJ; Smithson N; Carter RL; Gledhill S; Lamb D; Wyllie AH; Carey FA
    J Pathol; 1996 Sep; 180(1):33-7. PubMed ID: 8943812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heterozygosity at chromosomal regions 3p and 13q in non-small-cell carcinoma of the lung represents low-frequency events.
    Becker D; Sahin AA
    Genomics; 1989 Jan; 4(1):97-100. PubMed ID: 2536637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple genetic alterations in small-cell lung carcinoma.
    Yokota J; Mori N; Akiyama T; Shimosato Y; Sugimura T; Terada M
    Princess Takamatsu Symp; 1989; 20():43-8. PubMed ID: 2577337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.